Prevention of bone loss in kidney graft recipients

Transplant Proc. 2001 Feb-Mar;33(1-2):1144-5. doi: 10.1016/s0041-1345(00)02464-7.
No abstract available

MeSH terms

  • Adult
  • Alendronate / therapeutic use
  • Bone Density
  • Bone Resorption / etiology
  • Bone Resorption / physiopathology
  • Bone Resorption / prevention & control*
  • Calcitriol / therapeutic use
  • Calcium / therapeutic use
  • Calcium Carbonate / therapeutic use
  • Calcium Channel Agonists / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / physiology
  • Male
  • Methylprednisolone / therapeutic use
  • Osteoporosis, Postmenopausal / etiology
  • Osteoporosis, Postmenopausal / prevention & control
  • Vitamin D / therapeutic use

Substances

  • Calcium Channel Agonists
  • Glucocorticoids
  • Vitamin D
  • Calcitriol
  • Calcium Carbonate
  • Calcium
  • Alendronate
  • Methylprednisolone